fbpx

COVID-19大流行期間的醫療費用趨勢 Medical cost trend in the midst of the COVID-19 pandemic

由於2020年上半年僱主醫療保健支出下降以及下半年支出的不確定性,HRI預計相對於2020年估計的醫療保健費用,2021年醫療費用趨勢將COVID-19標準化,而不是實際的2020年的成本。 HRI制定了三種方案,以幫助僱主和衛生計劃制定2021年醫療費用趨勢:

高支出:支出在2020年下降之後,到2021年將大幅增長。
中度支出:2021年的支出增長率與2014年至2019年的增長率大致相同。
低支出:2021年支出仍將減少。

僱主將在2020年承擔計劃外的COVID-19測試和治療費用,而這些費用可能會在2021年繼續。到2020年,預計這些計劃外費用將被病毒大流行期間延遲護理節省的費用所抵消。隨著對護理需求的回歸,預計2021年支出將增加。

Because of the drop in employer healthcare spending in the first half of 2020 and the uncertainty around spending in the second half of the year, HRI is projecting 2021 medical cost trend relative to 2020 estimated healthcare costs, normalizing for COVID-19, rather than actual 2020 costs. HRI has developed three scenarios to guide employers and health plans as they determine 2021 medical cost trend:

High-spending scenario: Spending grows significantly higher in 2021 after being down in 2020.
Medium-spending scenario: Spending grows at roughly the same rate in 2021 as it did from 2014 to 2019 and was expected to in 2020.
Low-spending scenario: Spending remains dampened in 2021.

Employers are incurring unplanned COVID-19 testing and treatment costs in 2020, and those costs likely will continue in 2021. In 2020, these unplanned costs are expected to be more than offset by the savings from delayed care during the pandemic. An increase in spending is expected in 2021 as the demand for care returns.

PWC
https://www.pwc.com/us/en/industries/health-industries/library/behind-the-numbers.html

發佈留言

發佈留言必須填寫的電子郵件地址不會公開。 必填欄位標示為 *